Form Heading

Tag: chronic kidney disease


  • Second Sight Medical Products, Inc. (NASDAQ: $EYES) Spikes Up
    Shareholders of Second Sight Medical Products, Inc. (NASDAQ: EYES) appear to be the happiest on Wall Street. A few days ago, the FDA approved the company's Argus 2s Retinal Prosthesis System to treat retinitis pigmentosa (RP). As a result, in a few days, the share price increased more than 100%. I believe that the share price may continue its upward trend. Let's see why. …
  • Expect 40%-50% Reduction In Guidewire’s Share Price
    I believe that Guidewire Software is very overvalued at 10x-12x sales. Using the valuation of peers of 3.9x sales, I would see a reduction of 40%-50% in the share price justifiable. In my opinion, …
  • Kid Castle Educational Corp. (OTCMKTS:KDCE) Spikes Up
    After spiking up from the level of $0.75 to the $2.25 mark, the share price of Kid Castle Educational Corp. (KDCE) closed near $1.25. Besides, in less than two days, the company moved more than 1 …
  • $NIO Appears To Be A Long Term Opportunity
    NIO traders are buying shares at 6x-7.7x 2022 sales. I believe that the company is not that expensive with triple digit sales growth and double digit gross profit margin. However, shareholders need to understand that there are significant risks to factor in. Conservative individuals who don’t like share price volatility should pass on NIO. The company will most likely deliver stock returns in the long term. …

Login to your account below

Fill the forms bellow to register

Retrieve your password

Please enter your username or email address to reset your password.